An emotional risk might not deliver happy results, today is a below-zero day in the sky and the people or situation might not be compassionate. A renewed determination ...
There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show ...
Pharvaris recently presented long-term clinical data at ACAAI 2025, showing deucrictibant achieved a sustained 92.4% reduction in hereditary angioedema attacks over nearly three years, while also ...
Pfizer said it would buy a clinical stage biopharma company for up to $7 billion, as it eyes the lucrative weight-loss drug market currently dominated by Eli Lilly and Novo Nordisk. Novo Nordisk Stock ...